Background. The emergence of resistance amongst commensal flora is a serious threat to the community. However, there is paucity of data regarding antibiotic resistance in commensals in the absence of antibiotic pressure.
INTRODUCTION
Introduced as a broad spectrum antibiotics in the 1960s, quinolones and fluoroquinolones are one of the most commonly prescribed antimicrobials for the treatment of various bacterial infections. However, recent studies from across the globe have highlighted the widespread resistance to fluoroquinolones, especially in members of Enterobacteriaceae like Klebsiella and Salmonella Typhi [1] [2] [3] . Resistance to fluoroquinolones is primarily attributed to mutations in the quinolone resistance determining region (QRDR) of DNA gyrase (gyrA, gyrB) and topoisomerase IV (parC, parE) encoding genes. The mutations alter the conformation of amino acids within DNA gyrase and topoisomerase IV of the bacterial cell, the targets for quinolones [4] . In the late 1990s, plasmid-mediated quinolone resistance (PMQR) genes were discovered. The PMQR mechanisms usually mediate lower level resistance below the susceptible MIC breakpoints and can be transferred horizontally, leading to rapid dissemination of resistance.
The first PMQR gene to be described was qnrA and encodes a 218 amino acid pentapeptide repeat protein that interacts with DNA-gyrase and topoisomerase IV to prevent quinolone inhibition [5] . In the following years, several distantly related plasmid-mediated Qnr determinants were described in Enterobacteriaceae (QnrB, QnrC, QnrD, QnrS) [6] . Another PMQR determinant is the aac(6¢)-Ib-cr gene, which encodes a variant of aminoglycoside acetyltransferase. The variant enzyme has acquired the ability to acetylate ciprofloxacin and norfloxacin and reduces ciprofloxacin's activity fourfold [7] . The third is the qepA gene, which encodes a major facilitator subfamily quinolone-specific efflux pump [8] .
The effect of selective pressure of antibiotics by human and non-human use and transfer of resistance through various genes may contribute to the spread of antimicrobial resistance [9] . As most of the studies have focussed on clinical isolates to determine antimicrobial resistance, the extent of drug resistance and the effects of selective pressure in healthy individuals in the community remains undetermined especially in India. The human gut is a highly populated ecosystem where resistance amongst commensal flora can be transferred to other organisms in the micro-biota including pathogens. These can in turn be a source of extra intestinal infection and spread resistance to other hosts [10] . Although widely used in adults, fluoroquinolones (like ciprofloxacin) are not approved for routine use in children due to concerns regarding cartilage toxicity [11] . Gut colonization of neonates with Enterobacteriaceae isolates resistant to ciprofloxacin and nalidixic acid (NA) can help us understand whether resistance to antimicrobials can occur in unexposed individuals. In the present study, we used gut colonization in antibiotic naïve neonates to evaluate fluoroquinolone resistance in the community in the absence of selection pressure. This study also investigated the mechanism of resistance and the prevalence of various PMQR genes (qnr, aac(6¢)-Ib-cr, qepA).
METHODS Design overview, setting and participants
In this prospective study all low birth weight (LBW) neonates (!1500 to <2500 g) born at the Safdarjung Hospital, New Delhi, India (2009-2011) were eligible and enrolled to the study: 'Effect of probiotic VSL#3 on prevention of sepsis during 0-2 month period' [12] . This was a double-blind study in which the neonates were randomized to receive either VSL#3 for 30 days in the intervention group or physically similar preparation (Maltdextrin) in the control group. The results of this study have been previously published [12] . Approval for the study was obtained from the Institutional Ethics Committee. Consent was obtained from parents of each neonate before enrolment. Only vaginally delivered, healthy, exclusively breastfed neonates with LBW were included. The exclusion criteria were gross congenital malformations, hospitalization, extreme prematurity (<34 weeks), predisposing factors for sepsis, antibiotics use by mother/neonates (antibiotic use during pregnancy by mother and by neonates during the study period). After discharge from the hospital, trained field workers visited the newborns for probiotic supplementation and related complications up to 60 days of life. Stool samples from 100 randomly selected LBW neonates were used to study gut colonization with fluoroquinolone-resistant Enterobacteriaceae. The selection was computerized to include a balance of babies from both the probiotic and control arm [12] . These strains were earlier screened for extended spectrum b-lactamase (ESBL), AmpC and carbapenemase producing Enterobacteriaceae [13] . Co-occurrence of resistance to fluoroquinolone and third generation cephalosporin is also highlighted in this study.
Study of colonization by Enterobacteriaceae
Stool samples were collected on day (D)1, D21 and D60, serially diluted and plated on the MacConkey agar without antibiotics to study dominant gut flora. The D1 sample was the first stool passed after birth (meconium). Different colony types of Gram-negative bacteria which were judged to differ in morphology (size, shape, consistency and colour) from each sample were enumerated separately and identified using conventional biochemical tests including nitrate reduction test, catalase test, oxidase test, SIM medium (sulphur production, indole production and motility), triple sugar iron test, citrate utilization test, urease production, methyl red test, voges proskauer test and fermentation of sugars like glucose, sucrose, lactose, sorbitol, amino acid decarboxylation tests (lysine, ornithine and arginine) and phenylalanine deaminase test.
Phenotypic assessment
All Enterobacteriaceae isolates were screened for NA and ciprofloxacin susceptibility using disk diffusion and E-test methods (AB BIODISK, Solna, Sweden) as per CLSI guidelines [14] . They had also been screened earlier for ESBL using disk diffusion and E-test methods [14] and plasmid mediated AmpC or hyperproduction using AmpC disc test [15] . Suspected carbapenem-resistant Enterobacteriaceae (CRE) isolates with resistance to any one carbapenem [14] , i.e. ertapenem (MIC) >0.25 µg ml À1 ), imipenem and meropenem (MIC >1 µg ml À1 ) by E-test (bioM erieux, France) were tested for metallo-b-lactamase production using imipenem/ethylenediamine tetra-acetic acid E-test and for non-metallo-carbapenemase, especially KPC, production by the modified Hodge test (MHT) [14] .
Molecular characterization of antimicrobial susceptibility
In 28 randomly selected neonates, all Enterobacteriaceae isolates non-susceptible to NA were characterized for the presence of PMQR genes [qnr(A, B and S), qepA and aac (6¢)-Ib-cr ] and mutation in QRDR of gyrA and parC genes by specific primers (Table S1 , available in the online version of this article).
For aac(6¢)-Ib-cr gene identification, initially the presence of the aac(6¢)-Ib gene was determined by PCR with a specific primer. Those strains with the aac(6¢)-Ib gene were subjected to random amplification of polymorphic DNA (RAPD) with a set of three primers described earlier (Table S1 ) to determine whether the aac(6¢)-Ib-cr variant is present. RAPD patterns were considered to be of the variant type when the banding pattern differed by at least one band (Fig. S1 ).
As published earlier, the Enterobacteraceae isolates from these newborns had also been characterized for ESBL [bla-TEM , bla SHV (self designed), bla CTX-M (group1, 2, 8, 9 and 25)] and ampC (MOX, CIT, DHA, ACC, EBC and FOX) genes [13] . PCR for VIM, IMP, KPC and NDM-1 genes had also been performed for suspected CRE [13] .
Sequence analysis
The QRDR of gyrA and parC genes of all isolates resistant or intermediate resistant to NA and ciprofloxacin were further subjected to sequence analysis to determine the mutation pattern. Sequencing was performed as per the manufacturer's guidelines in 3130xl Genetic Analyzer (Applied Biosystems, Foster City, CA, USA). Further, the nucleotide and deduced amino acid sequences were analysed and compared with sequences available in the gene bank at the National Center of Biotechnology Information (NCBI) website (http://ncbi.nim.nih.gov).
RESULTS
Colonization pattern of Enterobacteriaceae in neonatal gut and distribution of fluoroquinolone resistance A total of 100 neonates were enrolled in the study including 52 males and 48 females. We isolated 343 Enterobacteriaceae from a total of 300 stool samples collected from 100 neonates on three different occasions. A total of 185 stool samples were positive for Enterobacteriaceae. On D1, 96 strains of Enterobacteriaceae were isolated from 58 babies; on D21, 115 Enterobacteriaceae were isolated from stool samples of 60 babies and on D60 132 isolates were collected from 67 babies. E. coli was the predominant flora on all three occasions followed by Klebsiella spp. The total number of Enterobacteriaceae isolates and E. coli was in linear progression from D1 to D60 (Fig. 1 ).
There was no significant difference between the antimicrobial susceptibility profile of isolates from the probiotic group and the control group. There was no net increase in NA-resistant (NAR) Enterobacteriaceae isolates with 60 % resistance overall. In contrast, resistance to ciprofloxacin significantly increased from 15 % (14/96) on D1 to 38 % (50/132) on D60 with P-value<0.001. As published earlier, the ESBL rate also increased from D1 (9/96) to D60 (41/ 103) which is statistically significant (P-value <0.0001). On the other hand, the presence of AmpC-b-lactamases was relatively constant with an average of 18 % (61/343) throughout the study period (Fig. 2, Table 1 ). Only one strain of Enterobacter aerogenes tested positive for carbapenemases production by MHT and the presence of the kpc-2 gene was confirmed by PCR.
The number of strains resistant to both fluoroquinolone and third-generation cephalosporins increased from 4.2 % (4/96) on D1 to 22.7 % (30/132) on D60, P-value=0.04. Among these strains, three out of four on D1 and 16 out of 30 on D60 demonstrated both ESBL and AmpC production in conjugation with fluoroquinolone resistance, showing only ESBL production in combination to fluroquinolone resistance. There were four isolates on D1 and two isolates each on D21 and D60, which were only resistant to NA and sensitive to ciprofloxacin but demonstrated ESBL and AmpC production ( Table 1 ).
Molecular analysis of fluoroquinolone resistance isolates Molecular analysis of fluoroquinolone resistance mechanisms was carried out in isolates from 28 randomly selected neonates. From these neonates we recovered 92 Enterobacteriaceae isolates (19, 32 and 41 on D1, D21 and D60 respectively).
Distribution of PMQR genes
The total number of isolates carrying qnr genes were 22 which increased from D1(N=3) to D60 (N=16). Of these, three carried qnrB, nine qnrS, seven qnrA and three strains carried both qnrA and qnrS. The aac(6¢)-Ib-cr gene was detected in one strain on D1, seven on D21 and seven on D60 by RAPD. Distribution of the qepA gene was two strains on D1, eight on D21 and eleven on D60.
QRDR mutation
There were 49 isolates with mutations in the QRDR. None of the isolates had a mutation in the QRDR of the parC gene. Sequencing of the QRDR of the gyrA gene showed the presence of four different single mutations (S83L, S83A, S83V, E139K) and two double mutations (S83L+D87 N, S83L+D87Y) (Table S2 ). Mutations outside the QRDR were also detected (E139K, K154R+S171A, S83L+E139K). Double mutations in the QRDR (S83L+D87 N, S83L+D87Y) were related to high-level fluoroquinolone resistance. The common mutations found were S83L (N=23), S83L+D87 N (N=16), S83A (N=3), S83L+D87Y (N=2), K154R+S171A (N=2), S83V (N=1), E139K (N=1) and S83L+E139K (N=1). The number of mutations increased from D1 (N=10) to D60 (N=21). There was a significant increase in S83L+D87 N mutation associated with increased fluoroquinolone resistance from D1 (N=1) to D60 (N=10) (P-value=0.04).
The detected molecular mechanisms of resistance were compared with the phenotypic susceptibility patterns using CLSI and EUCAST breakpoints. According to the CLSI breakpoints, Enterobacteriaceae strains with ciprofloxacin MICs of 1 µg ml À1 are susceptible, those with 2-4 µg ml À1 are intermediate susceptible and those with MIC !4 µg ml À1 are resistant to ciprofloxacin. On the other hand, EUCAST guidelines define strains with ciprofloxacin MIC 0.25 µg ml À1 as susceptible and !0.5 µg ml À1 as resistant. For NA, MIC breakpoints are defined by CLSI ( 16 µg ml À1 is susceptible, !32 µg ml À1 is resistant) but not by EUCAST. It was observed that strains with a single mutation in QRDR were NAR in 11 out of 13 cases but were ciprofloxacin susceptible (CipS) in the majority of cases as per both CLSI and EUCAST breakpoints with MIC50 of 0.25 µg ml À1 ( Table 2 ). The presence of two mutations even without any PMQR genes led to ciprofloxacin resistance in five out of six strains using either guidelines with MIC50 of 12. Two double mutations (S83L+D87 N, S83L+D87Y) were related to high-level fluoroquinolone resistance. In the strains carrying only PMQR genes with no mutations in QRDR, all strains were NAR/CipS except one which had decreased ciprofloxacin susceptibility (DCS) according to CLSI guidelines. This strain with MIC of 3 µg ml À1 was interpreted as ciprofloxacin resistant (CipR) as per EUCAST breakpoints. Overall, 29 strains harboured both QRDR mutations and PMQR genes. Nine of the 15 strains with single mutation in QRDR with PMQR were CipS, one had DCS whereas five strains were CipR as per CLSI. In comparison, according to EUCAST, the number of CipS strains was eight whereas seven strains were CipR. The presence of two mutations with PMQR genes led to resistance in nine of the 14 strains and five strains were ciprofloxacin susceptible as per CLSI. The number of CipR changed to 10 as per EUCAST guidelines.
Frequency distribution of ciprofloxacin MICs showed that the isolates with high-level resistance to ciprofloxacin had multiple mutations in QRDR or harboured concurrent QRDR mutation/s and PMQR genes (Table 3) .
DISCUSSION
In the present study, quinolone and fluoroquinolone resistance amongst Enterobacteriaceae in gut flora of antibiotic naïve neonates was investigated. It was ensured that there was no selection pressure by rigorous selection criteria and follow-up of the infants by household visits by trained field workers. Neonates delivered to mothers without exposure to antibiotics in the antenatal period and exclusively breastfed during the study period were included.
A large number (58 %) of babies were colonized on D1 of birth probably acquiring the mother's flora during vaginal delivery. It was observed that high prevalence of resistance to NA (60 %) existed even on D1 and persisted throughout the study period. On the other hand, the ciprofloxacin resistance was 15 % on D1 and increased more than twofold to 38 % by D60. This finding suggests that resistant bacteria can colonize the intestine of those humans who have not been exposed to fluoroquinolones and have no selection pressure directly or even indirectly as was observed on D1 of birth. A study from Seattle in the USA in 2006 had reported a 2.9 % colonization with CipR Gram-negative bacteria in children with no antibiotic exposure [16] . Another study conducted after a decade found that the gut colonization with CipR bacteria had now increased to 19 % in healthy twins [17] . Increasing fluoroquinolone resistance rates in commensal E. coli in children were also found in South America, Africa and Asia [18, 19] . Although, these studies were conducted on children, none of the isolates were from neonates. The presence of high-level resistance on D1 of birth is a unique finding of our report.
The probable source of acquisition of these resistance genes is through maternal flora at birth. Colonization of mucosa in the digestive, respiratory, urogenital tracts, as well as the skin begins at, or perhaps even before, the time of birth when a new-born is exposed to a mother's microbiota [20] . It was earlier thought that the in utero environment is sterile but recent studies have reported the presence of a number of commensal organisms from the placenta and foetal meconium including proteobacteria like Enterobacteriaceae. This flora shares similarity with human oral microbiota [21] . After birth, exposure to maternal and household environment, oral and skin flora of family members are major sources of bacteria. Breastmilk contains a variety of organisms with a microbiota composed of skin-and entericassociated bacteria. These organisms are transferred from maternal and infant microbial flora into breastmilk from skin, infant oral cavity into the mammary gland during breastfeeding and via entero-mammary transfer from the gut of the mother [22] . The authors of the American studies have attributed food intake especially poultry or family members as the possible source of resistant bacteria (33 % of children had at least one family member with a positive stool sample in the latter study) [17] . Studies have also supported that exposure to household pets in antenatal and early life also has an impact on the composition of gut microflora of infants [23] . Hence the most probable source of acquisition of the fluoroquinolone-resistant Enterobacteriaceae in antibiotic naïve neonates is likely to be the maternal flora and the other immediate environmental sources.
The limitation of our study is that the environmental flora and that of the family members was not studied and compared to the neonatal gut flora. The correlation between the flora of these ecosystems can definitively determine the source of resistance genes in healthy neonates.
The increased resistance to fluoroquinolones on D1 through D60 in non-hospitalized, exclusively breastfed, antibiotic naïve neonates is suggestive of high-level fluoroquinolone resistance in the community. Reports of widespread resistance to fluoroquinolones amongst isolates from the community in India in recent years corroborate this finding [24] . Various studies have shown the presence of fluoroquinolone resistance among enteric pathogens like Salmonella spp (92-95 %) [3] , E. coli (78-89 %) [24] , Neisseria gonorrhoeae (94 %) [25] , N. meningitidis [26] and Mycobacterium tuberculosis (14.9-38.2 %) [27] in Delhi, India. This high-level resistance is probably driven by extensive use of fluoroquinolone in the community. The impact of ciprofloxacin prescription on the emergence of resistance has been well established. A study from Ireland reported that for uropathogenic E. coli, with one prescription per month, ciprofloxacin resistance was low (3 %) whereas in practices with 10 prescriptions per month ciprofloxacin resistance amounted to 5.5 % [28] . Similarly, a study from Denver observed that as the prescriptions increased from 3.1 to 12.7 per 1000 visits; in parallel, fluoroquinolone resistance increased from 1 to 9 % [29] . In India, there is rampant use and misuse of fluoroquinolones. They have been used as first-line antibiotics for treatment of acute respiratory tract, diarrheal, urinary tract infections as well as serious infections like bacteraemia and MDR-tuberculosis [30] . They are one of the most frequently prescribed antimicrobials in the public as well as private sector with 9-14 % of all prescriptions having one member of this class [31] . In addition, self medication and the illegal sale of antibiotics over the counter is also commonplace in India. Additionally, chloroquine is advocated as a first-line drug for treatment of malaria in India [32] . Various studies have suggested that heavy use of chloroquine can select for ciprofloxacin resistance [33] .
In our study, QRDR mutations were the major cause of resistance to fluoroquinolones (49/92 isolates). In addition, 29 of these strains also harboured at least one PMQR gene. There was a fivefold increase in the number of isolates with PMQR genes from D1 (n=6) to D60 (n=35), most likely due to transfer within the gut flora. The number of isolates with QRDR mutations increased twofold especially double mutations (S83L+D87 N). Mutations were found most frequently in Ser-83 and Asp-87 codons, the hotspots in the QRDR. We also detected unique mutations outside the QRDR (E139K, K154R+S171A, S83L+E139K). Therefore, our study supports the finding that different mechanisms of resistance have a varied effect on the MIC values of fluoroquinolones [34] This study shows that a single QRDR mutation resulted in a fourfold rise in MIC50 of ciprofloxacin compared to wild-type strains whereas a double mutation increased MIC50 200-fold. The presence of PMQR genes alone led to an only two to fourfold increase in MIC50. It was observed that the presence of both PMQR determinants and QRDR mutations in the isolates promote high-level ciprofloxacin resistance with up to a 500-fold increase in MICs. The mutations present outside QRDR of DNA gyrase did not affect the ciprofloxacin MICs in our isolates. The number of strains resistant to both fluoroquinolone and third-generation cephalosporins increased over fivefold from D1 (4.2 %) to D60 (22.7 %), P-value=0.04. Half of these strains, carried both ESBL and AmpC genes in conjugation with fluoroquinolone resistance. This finding suggests that PMQR determinants are frequently associated and co-transferred with plasmid-mediated ESBL and AmpC genes as reported previously [35] . High load of PMQR in the gut flora is alarming as they are a potential source for transfer of these genes to pathogenic organisms.
Endogenous translocation of gut flora is one of the major causes of infections of the urinary tract, respiratory tract and bacteraemia [36] . This reservoir of resistant flora in the gut of neonates can lead to increased frequency of infections with multidrug-resistant organisms with severely limited treatment options resulting in therapeutic failures. Even healthy children can therefore become vehicles of transmission of resistance in the community.
Conclusion
The presence of fluoroquinolone resistance in antibiotic naïve neonates on D1 suggests acquisition from maternal vaginal flora during delivery. The increase in resistance can be attributed to exposure to family members and environmental sources. This is indicative of the tremendous load of antibiotic resistance in the community. The high load of PMQR in the commensal flora is alarming as they are a potential source for transfer of these genes to pathogenic organisms. 
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